Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PHARMAS

Financiado

Cerrado

Ecological and human health risk assessments of antibiotics and anti cancer drug...

Ecological and human health risk assessments of antibiotics and anti cancer drugs found in the environment. A consortium of world-class scientists from both academia and industry has been assembled to assess the risks to wild animals and humans posed by environmental exposure to pharmaceuticals. Their expertise will be supplemented by... ver más

31/03/2014

BRUNEL UNIVERSITY...

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

BRUNEL UNIVERSITY LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 14 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-03-31 No tenemos la información de la convocatoria

0% 76% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

14 Participantes

BRUNEL UNIVERSITY LONDON

0.00€ | Lider

ECOLOGIC INSTITUT gemeinnütz...

N.D. | Participante

EHESP

N.D. | Participante

NC3Rs

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

BRUNEL UNIVERSITY LONDON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 4M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto A consortium of world-class scientists from both academia and industry has been assembled to assess the risks to wild animals and humans posed by environmental exposure to pharmaceuticals. Their expertise will be supplemented by an advisory group consisting of representatives of all stakeholders. This project will concentrate on two classes of human pharmaceuticals, namely antibiotics and anti-cancer drugs, because there are good reasons for thinking that these could be of particular concern. In order to conduct sound risk assessments, including providing estimates of uncertainty, it will be necessary to obtain accurate data on both exposure concentrations and effects levels. Hence, new data on both environmental concentrations and effects on aquatic organisms will be produced during the project. The comparative sensitivities of embryos and adults will be determined, and used to reduce uncertainty in the risk assessments. The stable transformation products of the selected pharmaceuticals will also be investigated. All stakeholders and beneficiaries will be represented in the project, so that results are rapidly and reliably transferred to all interested parties. A prototype web-based classification system will be developed during the project with the intention of enabling all EU citizens to make their own informed decisions about the risk posed by human pharmaceuticals to their health and to the health of the environment. The results will able EU regulators and policy makers to make better informed decisions on the issue of pharmaceuticals in the environment.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores